Chase Investment Counsel’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,700
Closed -$637K 103
2019
Q2
$637K Hold
13,700
0.32% 66
2019
Q1
$550K Hold
13,700
0.28% 69
2018
Q4
$630K Buy
+13,700
New +$630K 0.38% 59